AUREOBASIDIUM PULLULANS VAR. PULLUTANS: 27 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
27
Total FAERS Reports
0
Deaths Reported
0
Hospitalizations
27
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20140122 · Latest Report: 20230323
What Are the Most Common AUREOBASIDIUM PULLULANS VAR. PULLUTANS Side Effects?
#1 Most Reported
Throat irritation
7 reports (25.9%)
#2 Most Reported
Cough
7 reports (25.9%)
#3 Most Reported
Anaphylactic reaction
6 reports (22.2%)
All AUREOBASIDIUM PULLULANS VAR. PULLUTANS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cough | 7 | 25.9% | 0 | 0 |
| Throat irritation | 7 | 25.9% | 0 | 0 |
| Anaphylactic reaction | 6 | 22.2% | 0 | 0 |
| Pruritus | 5 | 18.5% | 0 | 0 |
| Swelling | 5 | 18.5% | 0 | 0 |
Who Reports AUREOBASIDIUM PULLULANS VAR. PULLUTANS Side Effects? Age & Gender Data
Gender: 88.6% female, 11.4% male. Average age: 45.2 years. Most reports from: US. View detailed demographics →
Is AUREOBASIDIUM PULLULANS VAR. PULLUTANS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 6 | 0 | 0 |
| 2016 | 6 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 2 | 0 | 0 |
| 2021 | 2 | 0 | 0 |
| 2022 | 3 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for AUREOBASIDIUM PULLULANS VAR. PULLUTANS
Official prescribing information from the FDA-approved drug label.